✕
Login
Register
Back to News
Wells Fargo Maintains Overweight on Ultragenyx Pharmaceutical, Raises Price Target to $47
Benzinga Newsdesk
www.benzinga.com
Positive 92.5%
Neg 0%
Neu 0%
Pos 92.5%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment